OA09885A - Immunost imulation. - Google Patents

Immunost imulation.

Info

Publication number: OA09885A
Authority: OA; OAPI
Prior art keywords: immunost; imulation; immunost imulation
Prior art date: 1991-08-13

Application number

OA60472A

Inventor

Andrew Francis Geczy

Gregory John Russell-Jones

Stephen John Duncan Bell

David Albert Cooper

Original Assignee

Biotech Australia Pty Ltd

St Vincents Hosp Sydney

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-08-13

Filing date

1994-02-10

Publication date

1994-09-15

1994-02-10 Application filed by Biotech Australia Pty Ltd, St Vincents Hosp Sydney filed Critical Biotech Australia Pty Ltd

1994-09-15 Publication of OA09885A publication Critical patent/OA09885A/en

Links

230000003308 immunostimulating effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Microbiology (AREA)
Mycology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

OA60472A 1991-08-13 1994-02-10 Immunost imulation. OA09885A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
AUPK772591		1991-08-13

Publications (1)

Publication Number	Publication Date
OA09885A true OA09885A (en)	1994-09-15

Family

ID=3775617

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
OA60472A OA09885A (en)	1991-08-13	1994-02-10	Immunost imulation.

Country Status (10)

Country	Link
EP (1)	EP0598813A4 (en)
JP (1)	JPH07500819A (en)
CA (1)	CA2115424A1 (en)
CZ (1)	CZ28294A3 (en)
HU (2)	HUT70269A (en)
NZ (1)	NZ243929A (en)
OA (1)	OA09885A (en)
SK (1)	SK13494A3 (en)
WO (1)	WO1993003762A1 (en)
ZA (1)	ZA926021B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001013948A1 (en) *	1999-08-20	2001-03-01	The General Hospital Corporation	Outer membrane protein a, peptidoglycan-associated lipoprotein, and murein lipoprotein as therapeutic targets for treatment of sepsis
US7117033B2 (en)	2000-05-08	2006-10-03	Brainsgate, Ltd.	Stimulation for acute conditions
US7561919B2 (en)	2002-11-14	2009-07-14	Brainsgate Ltd.	SPG stimulation via the greater palatine canal
US8010189B2 (en)	2004-02-20	2011-08-30	Brainsgate Ltd.	SPG stimulation for treating complications of subarachnoid hemorrhage
US9233245B2 (en)	2004-02-20	2016-01-12	Brainsgate Ltd.	SPG stimulation
US8055347B2 (en)	2005-08-19	2011-11-08	Brainsgate Ltd.	Stimulation for treating brain events and other conditions
CN106310293A (en)	2007-09-27	2017-01-11	免疫疫苗技术有限公司	Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
WO2009146523A1 (en)	2008-06-05	2009-12-10	Immunovaccine Technologies Inc.	Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
CN113876945A (en)	2011-10-06	2022-01-04	免疫疫苗技术有限公司	Liposome composition comprising adjuvant for activating or increasing TLR2 activity and application thereof
EP2878335B1 (en)	2013-11-10	2018-01-03	Brainsgate Ltd.	Implant and delivery system for neural stimulator
US10271907B2 (en)	2015-05-13	2019-04-30	Brainsgate Ltd.	Implant and delivery system for neural stimulator

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0109688A3 (en) *	1982-11-23	1986-12-03	The Wellcome Foundation Limited	Improved complexes, processes for obtaining them and formulations containing such complexes
US4459286A (en) *	1983-01-31	1984-07-10	Merck & Co., Inc.	Coupled H. influenzae type B vaccine
JPH0720878B2 (en) *	1983-11-21	1995-03-08	ザウエルカムフアウンデ−シヨンリミテツド	Improved conjugates, processes for their production and formulations containing the conjugates
NL8403195A (en) *	1984-10-19	1986-05-16	Nederlanden Staat	IMMUNOGENIC COMPLEXES AND VACCINES CONTAINING THESE.
CA1331355C (en) *	1986-04-21	1994-08-09	Bioenterprises Pty. Ltd	Immunopotentation
CA1340888C (en) *	1988-09-01	2000-02-01	Algis Anilionis	Vaccines and diagnostic assays for haemophilus influenzae
US5500366A (en) *	1990-09-18	1996-03-19	Biotech Australia Pty. Ltd.	Polynucleotide encoding T-cell epitopes of the protein TraT

1992
- 1992-08-10 EP EP9292917802A patent/EP0598813A4/en not_active Withdrawn
- 1992-08-10 CA CA002115424A patent/CA2115424A1/en not_active Abandoned
- 1992-08-10 JP JP5503956A patent/JPH07500819A/en active Pending
- 1992-08-10 HU HU9400233A patent/HUT70269A/en unknown
- 1992-08-10 SK SK134-94A patent/SK13494A3/en unknown
- 1992-08-10 CZ CS94282A patent/CZ28294A3/en unknown
- 1992-08-10 WO PCT/AU1992/000423 patent/WO1993003762A1/en not_active Ceased
- 1992-08-11 ZA ZA926021A patent/ZA926021B/en unknown
- 1992-08-12 NZ NZ243929A patent/NZ243929A/en unknown
1994
- 1994-02-10 OA OA60472A patent/OA09885A/en unknown
- 1994-12-07 HU HU94P/P00050P patent/HU210605A9/en unknown

Also Published As

Publication number	Publication date
CZ28294A3 (en)	1994-05-18
EP0598813A1 (en)	1994-06-01
JPH07500819A (en)	1995-01-26
ZA926021B (en)	1993-03-26
HUT70269A (en)	1995-09-28
CA2115424A1 (en)	1993-03-04
SK13494A3 (en)	1994-09-07
EP0598813A4 (en)	1994-09-14
WO1993003762A1 (en)	1993-03-04
HU210605A9 (en)	1995-05-29
HU9400233D0 (en)	1994-05-30
NZ243929A (en)	1994-12-22

Publication	Publication Date	Title
DE59204008D1 (en)	1995-11-16	Trachealstent.
ZA927792B (en)	1993-04-20	Anti-alpha6-integrin-antibodies.
ZA926482B (en)	1993-03-08	Cyanophenylpyrroles.
OA09885A (en)	1994-09-15	Immunost imulation.
ZA929590B (en)	1994-06-10	Diphenylsulphides.
DE69205795D1 (en)	1995-12-07	Mesoprotheseunterlage.
DE69203865D1 (en)	1995-09-07	Thermo-transferdrucksystem.
ZA929820B (en)	1993-06-23	Heisswinderschieber.
ZA925725B (en)	1993-03-10	Qinolin-2-yl-methoxybenzylhydroxyureas.
DE69204801D1 (en)	1995-10-19	Hydroxy- oder oxosubstituierte alkylcyclopentene.
ZA929331B (en)	1993-06-07	Quinolylmethoxyphenyl-acetamides.
ZA921865B (en)	1993-09-13	Isoxazole- and isothiazole-5-carboxamides.
DE59200703D1 (en)	1994-12-01	Polyketomethinfarbstoffe.
PH30999A (en)	1997-12-23	Benzoquinoxalines.
ZA927412B (en)	1993-04-02	Structure.
AU205P (en)	1992-11-17	TARANNA Danthonia richardsonii
AU204P (en)	1992-11-13	NIRIBI Chamelaucium uncinatum
GB9123866D0 (en)	1992-01-02	The napklip
GB9108026D0 (en)	1991-06-05	The adapt-a-bench
GB9112265D0 (en)	1991-07-24	The cyclite
GB9113764D0 (en)	1991-08-14	The decastyle
GB9115445D0 (en)	1991-09-04	The bootmate
GB9120350D0 (en)	1991-11-06	The quick-weigh
GB9121006D0 (en)	1991-11-13	The pantislip
GB9108025D0 (en)	1991-06-05	The adapt-a-bench